Senate passes approps
This article was originally published in The Gray Sheet
Executive Summary
Reconciled version of FY 2006 FDA appropriations bill (HR 2744) provides over $222.7 mil. to CDRH - "an increase of $7.8 mil. over the FY 2005 level" - and "fully funds FDA's device review program," AdvaMed says in a Nov. 4 release. The Senate agreed to the conference report Nov. 3 by an 81-18 vote. The House passed the same language Oct. 28 (1"The Gray Sheet" Oct. 31, 2005, In Brief)...
You may also be interested in...
FDA panel conflicts of interest
Reconciled FY 2006 FDA appropriations bill passes the House Oct. 28 with a "very watered-down" version of an advisory committee conflict-of-interest (CoI) provision, according to Rep. Maurice Hinchey (D-N.Y.), who succeeded in adding a CoI amendment to the original House bill in June. The final language requires that panel member conflicts of interest and waivers for conflicts be posted on FDA's website at least 15 days prior to a meeting or as soon as possible if the conflict is identified closer to the meeting date. Hinchey's amendment would have prohibited FDA from granting CoI waivers (1"The Gray Sheet" June 13, 2005, In Brief)...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.